Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1992;79:979-982
© 1992 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LETTERIE, G. S.
Right arrow Articles by CHOW, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LETTERIE, G. S.
Right arrow Articles by CHOW, G. E.

Effect of "Missed" Pills on Oral Contraceptive Effectiveness

GERARD S. LETTERIE, MD and GREGORY E. CHOW, MD

From the Reproductive Endocrinology Service, Department of Obstetrics and Gynecology, Tripler Army Medical Center, Honolulu, Hawaii.

Abstract

Objective: The purpose of this study was to determine whether missing pills in an oral contraceptive (OC) cycle resulted in folliculogenesis and eventual ovulation.

Methods: Fifteen women selected from a population requesting tubal reanastomosis were randomized into three groups and issued pill packs missing four consecutive pills in specific sequences, as follows: group I, days 1–4; group II, days 3–6; and group III, days 6–9. Serum was drawn for assay of LH, FSH, estradiol (E2), and progesterone, and serial ovarian ultrasound examinations were done to study follicular development throughout the cycle at 4-day intervals.

Results: No subject ovulated, as suggested by serum progesterone concentrations (not exceeding 0.63 ng/mL for any woman) and ultrasound assessment of follicular development (no follicular diameter exceeding 13 mm). The highest (mean ± standard deviation) serum concentrations of LH and FSH in any group (13.25 ± 18.71 and 14.40 ± 7.71 mIU/mL, respectively) and of E2 (44.35 ± 26.79 pg/mL) were observed during or immediately after the pill-free interval. Ovarian ultrasound examinations suggested suppressed folliculogenesis in all groups. No functional ovarian cysts were detected.

Conclusions: Oral contraceptives exerted a similar degree of pituitary and ovarian suppression even when the subjects missed four pills at varying times in a cycle. The anovulatory effect persisted when the OC pills were reinstituted and taken reliably after an interval of noncompliance.




This article has been cited by other articles:


Home page
Obstet GynecolHome page
J. L. Schwartz, M. D. Creinin, H. C. Pymar, and L. Reid
Predicting Risk of Ovulation in New Start Oral Contraceptive Users
Obstet. Gynecol., February 1, 2002; 99(2): 177 - 182.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Elomaa, S. Ranta, J. Tuominen, and P. Lahteenmaki
Charcoal treatment and risk of escape ovulation in oral contraceptive users
Hum. Reprod., January 1, 2001; 16(1): 76 - 81.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. C. J. M. Fauser and A. M. van Heusden
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences
Endocr. Rev., February 1, 1997; 18(1): 71 - 106.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American College of Obstetricians and Gynecologists.